Clinical trial
CP101 for the Treatment of Ulcerative Colitis
NCT05852574 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CP101 for the Treatment of Ulcerative Colitis
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- September 1, 2023
- Completion date
- December 1, 2025
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis